Posted on

pharmaceutical companies growing weed

Pharmaceutical companies growing weed

Canopy Growth serves the Canadian medical and recreational marijuana markets and distributes medical cannabis to international markets, including Germany. The company has strong global distribution channels with subsidiaries, joint ventures, and strategic partners that market its products around the world.

Jazz Pharmaceuticals (NASDAQ:JAZZ)

2. Valens

Jazz is not a pure-play medical cannabis company, and it also makes the sleep disorder drugs Xyrem, Xywav, and Sunosi, which account for more than two-thirds of its sales. Jazz also sells the cancer drugs Rylaze, Vyxeos, and Zepzelca.

Trulieve Cannabis is a vertically integrated U.S.-based cannabis company that grows medical cannabis and distributes medical cannabis products to its own retail dispensaries. The company’s primary operations are in Florida, where it runs more than 80 medical cannabis dispensaries and commands a market share of close to 50%. Trulieve also has operations in California, Connecticut, Massachusetts, Pennsylvania, and West Virginia.

1. Canopy Growth

Trulieve Cannabis (OTC:TCNNF)

The initial agreement will span for three years, but a term to automatically extend it for two-year periods at a time is included in the deal.

Adding to these notes, Canndoc’s Chairman Ehud Barak, former prime minister of Israel, said, “Our agreement with S.L.E., Israel’s leading company in distributing medical products, creates a complete supporting platform for supplying Canndoc’s GMP products to any location in Israel and for countries with similar regulations… Through its S.L.E. partnership, Canndoc has aligned itself with one of the most prominent pharmaceutical companies in the world, for the distribution of cannabis-based medical treatments to countries that recognize the value of these medicines for people in need.”

The Making Of New York’s $150 Million ‘Cannabis Campus’

The other big deal announced to date: a development and distribution deal between Novartis and Tilray.

Johnson & Johnson has also been getting its feet wet in the proverbial canna-pond. Back in 2017, the company’s incubator, JLABS @ Toronto, admitted a cannabinoid biotech research company for the first time ever.

Blackstone To Sell The Cosmopolitan Of Las Vegas For $5.65 Billion

SLE’s CEO Aviad Bossi commented the agreement allows the companies to pair a “well-established pharmaceutical distribution network” with a “high quality medical cannabis industry presence and market leadership.”